Skip to main content

Table 2 Injecting and sharing behaviors among 402 recruited IDUs

From: Ability to access community-based needle-syringe programs and injecting behaviors among drug users: a cross-sectional study in Hunan Province, China

 

Overall

Ability to access to NSP syringes‡

χ2-test

Venue stratification

χ2-test

  

<40%

40-70%

>70%

(χ2, p-value)

MDC

Community

NSP

(χ2, p value)

 

N (%)

N (%)

N (%)

N (%)

 

N (%)

N (%)

N (%)

 

Used drugs in the last 30 days (n = 402)*

Yes

398 (99.0)

139 (97.9)

55 (100)

204 (99.5)

 

74 (94.9)

171 (100)

153 (100)

 

No

4 (1.0)

3 (2.1)

0 (0)

1 (0.5)

2.89, p = 0.236

4 (5.1)

0 (0)

0 (0)

16.782, p < 0.001†

Frequency of injecting drugs in the last 30 days (n = 392)

<1 times / day

41 (10.5)

12 (8.8)

4 (7.4)

25 (12.4)

 

7 (9.6)

19 (11.1)

15 (10.1)

 

1-2 times / day

220 (56.1)

68 (50.0)

21 (38.9)

131 (64.9)

 

37 (50.7)

109 (63.7)

74 (50.0)

 

3-5 times / day

115 (29.3)

46 (33.8)

28 (51.9)

41 (20.3)

 

22 (30.1)

39 (22.8)

54 (36.5)

 

>6 times / day

16 (4.1)

10 (7.4)

1 (1.9)

5 (2.5)

29.439, p < 0.001†

7 (9.6)

4 (2.3)

5 (3.4)

15.236, p = 0.019†

Times of repeated use per needle/syringe before disposal in the last 30 days (n = 389)

0

4 (1.0)

0 (0)

3 (5.9)

1 (0.5)

 

0 (0)

0 (0)

4 (2.7)

 

1

248 (63.8)

81 (58.7)

26 (51.0)

141 (70.5)

 

49 (66.2)

111 (65.7)

88 (60.3)

 

2-5

131 (33.7)

54 (39.1)

22 (43.1)

55 (27.5)

 

21 (28.4)

57 (33.7)

53 (36.3)

 

6-9

1 (0.3)

1 (0.7)

0 (0)

0 (0)

 

1 (1.4)

0 (0)

0 (0)

 

≥10

5 (1.3)

2 (1.4)

0 (0)

3 (1.5)

6.84, p = 0.033†

3 (4.1)

1 (0.6)

1 (0.7)

0.151, p = 0.927

Average ± SD

1.62 ± 1.32

1.80 ± 1.45

1.55 ± 0.86

1.52 ± 1.31

 

1.93 ± 2.00

1.54 ± 1.05

1.56 ± 1.13

 

Shared syringes in the last 30 days (n = 400)

Yes

35 (8.8)

23 (16.3)

7 (12.7)

5 (2.5)

 

15 (19.5)

4 (2.3)

16 (10.5)

 

No

365 (91.2)

118 (83.7)

48 (87.3)

199 (97.5)

21.326, p < 0.001†

62 (80.5)

167 (97.7)

136 (89.5)

20.507, p < 0.001†

Number of times shared syringes in the last 30 days (n = 29)

1

10 (34.5)

9 (45.0)

1 (16.7)

0 (0)

 

8 (66.7)

0 (0)

2 (15.4)

 

2-5

16 (55.2)

9 (45.0)

5 (83.3)

2 (66.7)

 

4 (33.3)

3 (75.0)

9 (69.2)

 

≥6

3 (10.3)

2 (10.0)

0 (0)

1 (33.3)

4.83, p = 0.090

0 (0)

1 (25.0)

2 (15.4)

5.780, p = 0.056

Average ± SD

4.28 ± 6.85

4.15 ± 7.37

2.17 ± 0.98

9.33 ± 9.29

 

1.55 ± 0.93

6.75 ± 8.85

5.92 ± 8.78

 

Number of sharing partners in the last 30 days (n = 31)

1

10 (31.3)

5 (22.7)

5 (71.4)

0 (0)

 

4 (28.6)

1 (25.0)

5 (35.7)

 

2-5

20 (62.5)

15 (68.3)

2 (28.6)

3 (100)

 

9 (64.3)

3 (75.0)

8 (57.1)

 

6-9

1 (3.1)

1 (4.5)

0 (0)

0 (0)

 

0 (0)

0 (0)

1 (7.1)

 

≥10

1 (3.1)

1 (4.5)

0 (0)

0 (0)

6.73, p = 0.035†

1 (7.1%)

0 (0)

0 (0)

0.594, p = 0.743

Average ± SD

2.53 ± 1.98

2.82 ± 2.26

1.43 ± 0.79

3.00 ± 0.0

 

2.64 ± 2.50

2.25 ± 0.96

2.85 ± 1.99

 

Maximum number of group sharing partners in the last 30 days (n = 32)

1

2 (6.3)

1 (4.5)

1 (14.3)

0 (0)

 

1 (7.1)

0 (0)

1 (7.1)

 

2-5

28 (87.5)

20 (90.9)

5 (71.4)

3 (100)

 

13 (92.9)

4 (100)

11 (78.6)

 

6-9

2 (6.3)

1 (4.5)

1 (14.3)

0 (0)

3.19, p = 0.203

0 (0)

0 (0)

2 (14.3)

0.867, p = 0.648

Average ± SD

2.94 ± 1.68

2.86 ± 1.42

3.00 ± 2.71

3.33 ± 0.58

 

2.50 ± 0.76

2.50 ± 0.58

3.50 ± 2.35

 
  1. ‡ Ability to access to NSP syringes is defined as the proportion of syringes obtained from NSPs during the past 3 months at the time of survey.
  2. † p-value is significantly (<0.05) by Chi-2 test.
  3. * Number in bracket refers to the number of participants who answered the particular question.